---
title: "A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs"
description: "The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale."
author: "Rachel Suleymanov"
section: business
published: 2026-10-25T13:30:32.246221+00:00
canonical: https://valorandventures.media/article/76ca3cad-7e7c-4f00-b2b1-3ac7f4fe0235
publisher: "Valor & Ventures Media"
source: "Inc."
source_url: https://www.inc.com/rachel-suleymanov/nobel-prize-winner-startup-raised-350-million-dollars-now-cant-fund-cancer-programs/91416317
access: free
---

# A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs

*The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.*

## Article

---
Rachel Suleymanov · Inc.

---

Originally published by Inc.: https://www.inc.com/rachel-suleymanov/nobel-prize-winner-startup-raised-350-million-dollars-now-cant-fund-cancer-programs/91416317